Designs for clinical trials to test the efficacy of therapeutics in progressive multifocal leukoencephalopathy

References

• Berger J, Mucke L (1988). Prolonged survival and par-tial recovery in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 38: 1060–1065.
   PubMed Web of Science ®Google Scholar
• Berger J, Pall L, Lanska D, Whiteman M (1998). Progressive multifocal leukoencephalopathy in patients with HIV infection. I NeuroVirol 4: 59–68.
   Google Scholar
• Brambilla AM, Castagna A, Novati R, Cinque P, Terreni MR, Moioli MC, Lazzarin A (1999). Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy. J Neurol 246: 723–725.
   PubMed Web of Science ®Google Scholar
• Chang L, Ernst T, Tornatore C, Aronow H, Melchor R, Walot I, Singer E, Cornford M (1997). Metabolite abnormali-ties in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology 48: 836–845.
   Google Scholar
• Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop, NE (1999). HAART im-proves prognosis in HIV-associated progressive multifo-cal leukoencephalopathy. Neurology 52: 623–625.
   PubMed Web of Science ®Google Scholar
• Colin C, Wade DT, Davies S, Horne V (1988). The Barthel ADL index: a reliability study. Int Disabil Stud 10: 61–63.
   Google Scholar
• De Luca A, Ammassari A, Cingolani A, Giancola ML, Antinori A (1998). Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretrovi-ral therapy. AIDS 12: 1937–1938.
   Google Scholar
• De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Paglia M, Govoni A, Murri R, Testa L, Monforte A, Antinori A (2000a). Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifoc al leukoen-cephalopathy. AIDS 14: F117–121.
   Google Scholar
• De Luca A, Giancola ML, Ammassari A, Grisetti S, Paglia MG, Gentile M, Cingolani A, Murri R, Liuzzi G, d'Arminio Monforte A, Antinori A (2000b). The ef-fect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoen-cephalopathy. J Infect Dis 182: 1077–1083.
   PubMed Web of Science ®Google Scholar
• De Luca A, Giancola ML, Cingolani A, Ammassari A, Gillini L, Murri R, Antinori A (1999). Clinical and virological monitoring during treatment with int athec al cytarabine in patients with AIDS-associated progressive multifoc al leukoencephalopathy. Clin Infect Dis 28: 624–628.
   PubMed Web of Science ®Google Scholar
• Garcia de Viedma D, Alonso R, Miralles P, Berenguer J, Rodriguez-Creixems M, Bouza E (1999). Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evalua-tion and monitoring of progressive multifocal leukoen-cephalopathy in AIDS patients receiving highly active antiretroviral therapy. I Clin Microbiol 37: 724–728.
   Google Scholar
• Gasnault J, Kousignian P, Kahraman M, Delfraissy J-F, Taoufik Y (2001). Cidofovir in AIDS-associated progres-sive multifocal leukoencephalopathy: a monocenter ob-servational study with clinical and JC virus load moni-toring. I NeuroVirol, submitted.
   Google Scholar
• Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla A, Luke W, Lazzarin A, Weber T, Cinque P (2000). Highly active antiretroviral therapy and progressive multif o-cal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 30: 95–99.
   PubMed Web of Science ®Google Scholar
• Hall C, Dafni U, Simpson D, Clifford D, Wetherill P, Cohen B, McArthur J, Hollander H, Yiannoutsos C, Major E, Millar L, Timpone J (1998). Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. NEng/JMed 338: 1345–1351.
   Google Scholar
• Houston S, Roberts N, Mashinter L (2001). Failure of cidofovir therapy in progressive multifocal leukoen-cephalopathy unrelated to human immunodeficiency virus. Clin Infect Dis 32: 150–152.
   Google Scholar
• Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL (1999). JC virus DNA load in patients with and without pro-gressive multifoc al leukoencephalopathy. Neurology 52: 253–260.
   Google Scholar
• Koralnik IJ, DuPasquier RA, Letvin NL (2001). JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. I Virol 5: 3483–3487.
   Google Scholar
• Kurtzke JF (1983). Rating neurologic impairment in mul-tiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444–1452.
   PubMed Web of Science ®Google Scholar
• Marra CM, Rajicic N, Barker DE, Cohen BA, Clifford DC (2001). Prospective Pilot Study of Cidofovir for HIV-Associated Progressive Multifoc al Leukoencephalopa-thy (PML). 8th conference on retroviruses and oppor-tunistic infections, Chicago, Abstract 596.
   Google Scholar
• Miralles P, Berenguer J, Lacruz J, Lopez JC, Cosin J, Padilla B, Mutioz L, Garcea de Viedma L (2001). Paradoxical worsening of AIDS-associated progressive multifocal leukoencephalopathy following HAART. 8th conference on retroviruses and opportunistic infections, Chicago, Abstract 598.
   Google Scholar
• O'Brien P, Fleming T (1979). A multiple testing procedure for clinical trials. Biometrics 35: 549–556.
   PubMed Web of Science ®Google Scholar
• Silver SA, Arthur RR, Erozan YS, Sherman ME, McArthur JC, Uematsu S (1995). Diagnosis of progressive multi-focal leukoencephalopathy by stereotactic brain biopsy utilizing immunohistochemistry and the polymerase chain reaction. Acta Cytol 39: 35–44.
   Google Scholar
• Sindic C, Trebst C, Van Antwerpen M, Frye S, Enzensberger W, Hunsmann G, Luke W, Weber T (1997). Detection of CSF-specific oligoclonal antibodies to recombinant JC virus VP1 in patients with progressive multifocal leukoencephalopathy. J Neuroimmunol 76: 100–104.
   PubMed Web of Science ®Google Scholar
• Taoufik Y, Gasnault J, Karaterki A, Pierre Ferey M, Marchadier E, Goujard C, Lannuzel A, Delfraissy JF, Dussaix E (1998). Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifo-cal leukoencephalopathy. I Infect Dis 178: 1816–1820.
   PubMed Web of Science ®Google Scholar
• Tassie JM, Gasnault J, Bentata M, Deloumeaux J, Boue F, Billaud E, Costagliola D (1999). Survival improve-ment of AIDS-related progressive multifocal leukoen-cephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV. AIDS 13: 1881–1887.
   Google Scholar
• Weber T, Trebst C, Frye S, Cinque P, Vago L, Sindic C, Schulz-Schaeffer W, Kretzschmar H, Enzensberger W, Hunsmann G, Luke W (1997). Analysis of the systemic and intrathecal humoral immune response in progres-sive multifocal leukoencephalopathy. I Infect Dis 176: 250–254.
   PubMed Web of Science ®Google Scholar
• Weiner SM, Laubenberger J, Muller K, Schneider J, Kreisel W (2000). Fatal course of HIV-associated progres-sive multifoc al leukoencephalopathy despite success-ful highly active antiretroviral therapy. I Infect 40: 100–102.
   Google Scholar
• Yiannoutsos C, Major E, Curfman B, Jensen P, Gravell M, Hou J, Clifford D, Hall C (1999). Relation of JC virus DNa in the CSF to survival in AIDS patients with biopsy-proven progressive multifocal leukoen-cephalopathy. Ann Neurol 45: 816–820.
   PubMed Web of Science ®Google Scholar